These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 36586223

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.
    Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, Staroselskiy K, Vishnevskiy K, Lisovskaja V, Al-Shurbaji A, Guzman N, Bhandari S.
    J Am Soc Nephrol; 2019 Sep; 30(9):1723-1733. PubMed ID: 31201218
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Safety and efficacy of sodium zirconium cyclosilicate for the management of acute and chronic hyperkalemia in children with chronic kidney disease 4-5 and on dialysis.
    Khandelwal P, Shah S, McAlister L, Cleghorn S, King L, Shroff R.
    Pediatr Nephrol; 2024 Apr; 39(4):1213-1219. PubMed ID: 37857905
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hyperkalaemia and potassium binders: Retrospective observational analysis looking at the efficacy and cost effectiveness of calcium polystyrene sulfonate and sodium zirconium cyclosilicate.
    Huda AB, Langford C, Lake J, Langford N.
    J Clin Pharm Ther; 2022 Dec; 47(12):2170-2175. PubMed ID: 36114759
    [Abstract] [Full Text] [Related]

  • 30. Sodium Zirconium Cyclosilicate (ZS-9): A Novel Agent for the Treatment of Hyperkalemia.
    Linder KE, Krawczynski MA, Laskey D.
    Pharmacotherapy; 2016 Aug; 36(8):923-33. PubMed ID: 27393581
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A Real-World Experience of Hyperkalemia Management Using Sodium Zirconium Cyclosilicate in Chronic Hemodialysis: A Multicenter Clinical Audit.
    Qu X, Hua Y, Khan BA.
    Cureus; 2023 Sep; 15(9):e45058. PubMed ID: 37829953
    [Abstract] [Full Text] [Related]

  • 33. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia.
    Watson M, Abbott KC, Yuan CM.
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1723-6. PubMed ID: 20798253
    [Abstract] [Full Text] [Related]

  • 34. Potassium-lowering effects of sodium zirconium cyclosilicate in the early post-transplant period.
    Shockey W, Wiegel JJ, Parajuli S, Garg N, Swanson KJ, Mandelbrot DA.
    Clin Transplant; 2024 Jan; 38(1):e15156. PubMed ID: 37812572
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE.
    Roger SD, Spinowitz BS, Lerma EV, Singh B, Packham DK, Al-Shurbaji A, Kosiborod M.
    Am J Nephrol; 2019 Jan; 50(6):473-480. PubMed ID: 31658466
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review.
    Beccari MV, Meaney CJ.
    Core Evid; 2017 Jan; 12():11-24. PubMed ID: 28356904
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.